268 related articles for article (PubMed ID: 33945171)
1. Platelet-Lymphocyte ratio is a predictor for the development of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction after thrombus aspiration.
Şenöz O; Emren SV; Erseçgin A; Yapan Emren Z; Gül İ
J Clin Lab Anal; 2021 Jun; 35(6):e23795. PubMed ID: 33945171
[TBL] [Abstract][Full Text] [Related]
2. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
4. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
5. The Utility of the Platelet-Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction.
Yildiz A; Yuksel M; Oylumlu M; Polat N; Akyuz A; Acet H; Aydin M; Ülgen MS
Clin Appl Thromb Hemost; 2015 Apr; 21(3):223-8. PubMed ID: 24431380
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
7. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
8. The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Zhang Q; Hu M; Sun J; Ma S
Scand Cardiovasc J; 2020 Dec; 54(6):352-357. PubMed ID: 32597237
[TBL] [Abstract][Full Text] [Related]
9. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
[TBL] [Abstract][Full Text] [Related]
10. Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction.
Vakili H; Shirazi M; Charkhkar M; Khaheshi I; Memaryan M; Naderian M
Eur J Clin Invest; 2017 Apr; 47(4):322-327. PubMed ID: 28177528
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.
Çelik MC; Karayiğit O; Ozkan C; Dolu AK; Kalçık M
Angiology; 2023 Apr; 74(4):387-394. PubMed ID: 35857618
[TBL] [Abstract][Full Text] [Related]
12. Predictors of thrombus burden and no-reflow of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of platelet indices.
Cakici M; Cetin M; Balli M; Akturk E; Dogan A; Oylumlu M; Abus S; Yildiz E; Sungur A; Celiker M
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):709-15. PubMed ID: 24806326
[TBL] [Abstract][Full Text] [Related]
13. Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction.
Ren F; Mu N; Zhang X; Tan J; Li L; Zhang C; Dong M
Am J Med Sci; 2016 Sep; 352(3):261-6. PubMed ID: 27650230
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
16. Quantification Of Thrombus Burden As An Independent Predictor Of Intra-Procedural No-Reflow In Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Revascularization.
Kumar R; Khan KA; Shah JA; Ammar A; Kumar D; Khowaja S; Sial JA; Kazmi S; Murtaza M; Karim M
J Ayub Med Coll Abbottabad; 2022; 34(2):288-294. PubMed ID: 35576288
[TBL] [Abstract][Full Text] [Related]
17. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Tasar O; Karabay AK; Oduncu V; Kirma C
Coron Artery Dis; 2019 Jun; 30(4):270-276. PubMed ID: 31026233
[TBL] [Abstract][Full Text] [Related]
18. The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Somuncu MU; Akgun T; Cakır MO; Akgul F; Serbest NG; Karakurt H; Can M; Demir AR
J Atheroscler Thromb; 2019 Nov; 26(11):970-978. PubMed ID: 30996145
[TBL] [Abstract][Full Text] [Related]
19. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.
Gupta S; Gupta MM
Indian Heart J; 2016; 68(4):539-51. PubMed ID: 27543480
[TBL] [Abstract][Full Text] [Related]
20. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Quisi A; Alıcı G
J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
